| 產(chǎn)品編號(hào) | bs-4541R |
| 英文名稱(chēng) | Chloramphenicol Rabbit pAb |
| 中文名稱(chēng) | 氯霉素抗體 |
| 別 名 | Chloramphenicol; D-(− )-threo-2, 2-Dichloro-N-[beta-hydroxy-alpha-(hydroxymethyl)-beta-(4-nitrophenyl)ethyl]acetamide, D-(− )-threo-2-Dichloroacetamido-1-(4-nitrophenyl)-1, 3-propanediol, D-threo-2, 2-Dichloro-N-[beta-hydroxy-alpha-(hydroxymethyl)-4-nitrophenethyl]acetamide, Chloromycetin. |
 |
Specific References (2) | bs-4541R has been referenced in 2 publications.
[IF=2.475] Zhou et al. Rapid detection of chloramphenicol residues in aquatic products using colloidal gold immunochromatographic assay. (2014) Sensors.(Basel). 14:21872-88 GICA ; Chloramphenicol.
[IF=2.05] Zhou, Chennan, et al. "Rapid Detection of Chloramphenicol Residues in Aquatic Products Using Colloidal Gold Immunochromatographic Assay." Sensors 14.11 (2014): 21872-21888. other ;
|
| 研究領(lǐng)域 | 免疫學(xué) 藥物及化合物 |
| 抗體來(lái)源 | Rabbit |
| 克隆類(lèi)型 | Polyclonal |
| 交叉反應(yīng) | (predicted: Chloramphenicol) |
| 產(chǎn)品應(yīng)用 | ELISA=1:5000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | 0.32313 kDa |
| 檢測(cè)分子量 | |
| 性 狀 | Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | BSA conjugated Chloramphenicol |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| 保存條件 | Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| PubMed | PubMed |
| 產(chǎn)品介紹 |
Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae, isolated by David Gottlieb, and introduced into clinical practice in 1949. It was the first antibiotic to be manufactured synthetically on a large scale, and alongside the tetracyclines, is considered the prototypical broad-spectrum antibiotic. Chloramphenicol is effective against a wide variety of Gram-positive and Gram-negative bacteria, including most anaerobic organisms. Due to resistance and safety concerns, it is no longer a first-line agent for any indication in developed nations and has been replaced by newer drugs in this setting, although it is sometimes used topically for eye infections. In low-income countries, chloramphenicol is still widely used because it is exceedingly inexpensive and readily available. Database links: CAS Number 56-75-7 藥物 化合物抗體 |
